Novo Nordisk targets bigger slice of diabetes market with new tablet
September 23, 2019 at 07:31 AM EDT
Danish drugmaker Novo Nordisk is aiming for a big slice of the multibillion-dollar diabetes market with a new pill, approved by U.S. authorities on Friday, that caters for patients with an aversion to needles.